plateau on retatrutide Retatrutide for Weight Loss

The FDA has approved oral Wegovya daily pill option for weight loss that uses semaglutide, the same active ingredient as injectable GLP 1s. As Midi's Chief Medical Officer, Dr. Kathleen Jordan explains: if GLP 1 drugs are associated with a 35% higher risk of NAION, an eye condition that can cause sudden vision loss. About 6 to 10 extra cases per 10,000 users over 3 years. BREAKING #Retatrutide News!! In TRIUMPH 1, participants on 12 mg retatrutide lost an average of 70.3 lbs (28.3%) over 80 weeks with 45.3% of participants achieving 30% weight loss, a level long associated Effects of tirzepatide, a dual GIP and GLP 1 receptor agonist, on blood pressure, cardiac function, and sympathetic nervous system in stroke prone spontaneously hypertensive rats Hypertension Research Thinking about GLP 1 for weight loss? Here's the full scoop AOL